Stockscreener 앱 받기
0.4527
3.10%
-0.0145
시간 외 거래:
.47
0.0173
+3.82%
전일 마감가:
$0.4672
열려 있는:
$0.4478
하루 거래량:
10.07M
Relative Volume:
1.08
시가총액:
$3.49M
수익:
$52.63M
순이익/손실:
$-8.12M
주가수익비율:
-0.0364
EPS:
-12.45
순현금흐름:
$-42.02M
1주 성능:
+30.12%
1개월 성능:
-39.64%
6개월 성능:
-68.78%
1년 성능:
-90.61%
1일 변동 폭
$0.4325
$0.62
1주일 범위
$0.3201
$1.13
52주 변동 폭
$0.295
$5.37
Molecular Templates Inc Stock (MTEM) Company Profile
명칭
Molecular Templates Inc
전화
512 896 1555
주소
9301 AMBERGLEN BLVD, AUSTIN, TX
MTEM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MTEM | 0.4527 | 3.49M | 52.63M | -8.12M | -42.02M | -12.45 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-21 | 개시 | BofA Securities | Buy |
| 2021-02-01 | 개시 | UBS | Neutral |
| 2020-09-08 | 개시 | Jefferies | Buy |
| 2020-03-25 | 개시 | Stifel | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-04-29 | 개시 | UBS | Buy |
| 2018-12-11 | 개시 | Oppenheimer | Outperform |
| 2018-10-08 | 개시 | Laidlaw | Buy |
모두보기
Molecular Templates Inc 주식(MTEM)의 최신 뉴스
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register
Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register
Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - Investing.com India
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM
U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn
Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Clairity Appoints Jeffrey R. Luber as CEO - citybiz
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN
In-vitro Transcription Templates Market to Witness Robust Growth at 19.53% CAGR by 2031 - WhaTech
Bitdeer Technologies Holding Co (NASDAQ: BTDR) Is The Number One Stock Currently Moving. - Stocks Register
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Global Leukemia Therapeutics Market Overview And Statistics For 2024-2033 - EIN News
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Wall Street-Heavily Traded - WDRB
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Biotech Alert: Searches spiking for these stocks today - TipRanks
why Molecular Templates Inc [MTEM] is a Good Choice for Investors After New Price Target of $18.00 - The DBT News
Closing Bell Recap: Molecular Templates Inc (MTEM) Ends at 0.39, Reflecting a -73.48 Downturn - The Dwinnex
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
MTEM stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
MTEM stock touches 52-week low at $0.31 amid market challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - Benzinga
A closer look at MTEM’s price-to-free cash flow ratio - US Post News
Molecular Templates Inc (MTEM) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher - Benzinga
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction - Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket - Benzinga
Stocks to Watch: Boeing, Vera Bradley, Molecular Templates - Morningstar
Molecular Templates dips after board approves liquidation plan - XM
Molecular Templates Approves Liquidation, Wind Up of Company - MarketWatch
Molecular Templates : Reorganization Form 8 K - Marketscreener.com
Stocks to Watch : Boeing, Vera Bradley, Molecular Templates - Marketscreener.com
NIKE, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise - Simply Wall St
MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023 - MSN
Molecular Templates rises on workforce reduction plan - XM
Molecular Templates Inc (MTEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):